Kirsty F. Houslay

Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction

Elizabeth England, D. Gareth Rees, Ian C. Scott et al. · Scientific Reports · 2023 · 109 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Dimethyl fumarate blocks pro-inflammatory cytokine production via inhibition of TLR induced M1 and K63 ubiquitin chain formation

Victoria A. McGuire, Tamara Ruiz-Zorrilla Diez, Christoph H. Emmerich et al. · Scientific Reports · 2016 · 107 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

Oxidised IL-33 drives COPD epithelial pathogenesis<i>via</i>ST2-independent RAGE/EGFR signalling complex

Sam Strickson, Kirsty F. Houslay, Victor Augusti Negri et al. · European Respiratory Journal · 2023 · 82 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Identification of a multifunctional docking site on the catalytic unit of phosphodiesterase-4 (PDE4) that is utilised by multiple interaction partners

Kirsty F. Houslay, Christian Frank, Ruth MacLeod et al. · Biochemical Journal · 2016 · 34 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Mating opportunities and energetic constraints drive variation in age‐dependent sexual signalling

Thomas M. Houslay, Kirsty F. Houslay, James Rapkin et al. · Functional Ecology · 2016 · 21 citations

Life Sciences, Biology, Entomology +17